Antibacterial activity and endotoxin-binding capacity of Actisorb® Silver 220

Journal of Hospital Infection

Volumn 53, Issue 3, 2003, Pages 211-214

  Muller G ^a   Winkler, Y ^a   Kramer, A ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Actisorb Silver 220; Antibacterial activity; Endotoxin binding; Wound dressing

Indexed keywords

ENDOTOXIN; SILVER; CHARCOAL; SULFADIAZINE SILVER; TOPICAL ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DRUG BINDING; ENVIRONMENTAL RELEASE; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; NONHUMAN; NYLON FIBER; PSEUDOMONAS AERUGINOSA; WOUND DRESSING; WOUND INFECTION; BANDAGE; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HUMAN; MATERIALS TESTING; MICROBIOLOGY; STANDARD; TIME;

ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; CHARCOAL; ENDOTOXINS; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MATERIALS TESTING; PSEUDOMONAS AERUGINOSA; SILVER SULFADIAZINE; TIME FACTORS; WOUND INFECTION;

EID: 0038312003     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2002.1369     Document Type: Article

References (17)

1. Klasen, HJ (2000). A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns, 26 131-138.
2. Rudolph, P, Werner, H- P, Kramer, A (2000). Studies on the microbicidal efficacy of wound dressings. Hyg Med, 25 184-186.
3. Furr, JR, Russell, AD, Turner, TD, Andrews, A (1994). Antibacterial activity of Actisorb Plus, Actisorb and silver nitrate. J Hosp Infect, 27 201-208.
4. Sternberg, BD, Phillips, LG, Hokanson, JA, Heggers, JP, Robson, MC (1991). The effect of bFGF on the inhibition of contraction caused by bacterial. J Surg Res, 59 47-50.
5. Bacchetta, CA, Magee, W, Rodeheaver, G, Edgerton, MT, Edlich, RF (1975). Biology of infections of split thickness skin grafts. Am J Surg, 130 63-67.
6. Robson, MC, Krizek, TJ (1973). Predicting skin graft survival. J Trauma, 13 213-217.
7. Krizek, TJ, Robson, MC, Kho, E (1967). Bacterial growth and skin graft survival. Surg Forum, 18 518.
8. Vaara, M, Vaara, T (1983). Polycations as outer membrane-disorganizing agents. Antimicrob Agents Chemother, 24 114-122.
9. Hurley, JC (1995). Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Safety, 12 183-195.
10. Eng, RH, Smith, SM, Fan-Harvard, P, Ogbara, T (1993). Effect of antibiotics on endotoxin release from Gram-negative bacteria. Diagn Microbiol Infect Dis, 16 185-189.
11. Miragliotta, G (1991). Endotoxin release after antibiotic treatment and its potential pathogenic role in coagulative disorders of patients with Gram-negative sepsis. J Chemother, 3 69-72.
12. Dudley, MN (1990). Overview of Gram-negative sepsis. Am J Hosp Pharm, 47 S3-S6.
13. Metzger, Z, Nitzan, D, Pitaru, S, Brosh, T, Teicher, S (2002). The effect of bacterial endotoxin on the early tensile strength of healing surgical wounds. J Endodon, 28 30-33.
14. Kawaguchi, H, Hizuta, A, Tanaka, N, Orita, K (1995). Role of endotoxin in wound healing impairment. Res Commun Mol Pathol Pharmacol, 89 317-327.
15. Woltmann, A, Hamann, L, Ulmer, AJ, Gerdes, J, Bruch, H- P, Rietschel, ET (1998). Molecular mechanisms of sepsis. Langenbeck's Arch Surg, 383 2-10.
16. Martin, P (1997). Wound healing: aiming for perfect skin regeneration. Science, 276 75-81.
17. Thomas, A, Harding, KG, Moore, K (2000). Alginates from wound dressings activate human macrophages to secrete tumour necrosis factor-α. Biomaterials, 21 1797-1802.